401 related articles for article (PubMed ID: 36090974)
1. Lipid nanoparticle-based mRNA vaccines in cancers: Current advances and future prospects.
Huang T; Peng L; Han Y; Wang D; He X; Wang J; Ou C
Front Immunol; 2022; 13():922301. PubMed ID: 36090974
[TBL] [Abstract][Full Text] [Related]
2. Advances in mRNA vaccines.
Li M; Wang Z; Xie C; Xia X
Int Rev Cell Mol Biol; 2022; 372():295-316. PubMed ID: 36064266
[TBL] [Abstract][Full Text] [Related]
3. Delivery Strategies for mRNA Vaccines.
Ramachandran S; Satapathy SR; Dutta T
Pharmaceut Med; 2022 Feb; 36(1):11-20. PubMed ID: 35094366
[TBL] [Abstract][Full Text] [Related]
4. Lipid Nanoparticle (LNP) Enables mRNA Delivery for Cancer Therapy.
Zong Y; Lin Y; Wei T; Cheng Q
Adv Mater; 2023 Dec; 35(51):e2303261. PubMed ID: 37196221
[TBL] [Abstract][Full Text] [Related]
5. Circular RNA cancer vaccines drive immunity in hard-to-treat malignancies.
Li H; Peng K; Yang K; Ma W; Qi S; Yu X; He J; Lin X; Yu G
Theranostics; 2022; 12(14):6422-6436. PubMed ID: 36168634
[No Abstract] [Full Text] [Related]
6. Current Developments and Challenges of mRNA Vaccines.
Chen J; Chen J; Xu Q
Annu Rev Biomed Eng; 2022 Jun; 24():85-109. PubMed ID: 35231177
[TBL] [Abstract][Full Text] [Related]
7. R848 Adjuvant Laden With Self-Assembled Nanoparticle-Based mRNA Vaccine Elicits Protective Immunity Against H5N1 in Mice.
Zhuang X; Chen L; Yang S; Xia S; Xu Z; Zhang T; Zeng B; Yu T; Yu N; Wang W; Lu H; Tian M; Jin N
Front Immunol; 2022; 13():836274. PubMed ID: 35711431
[TBL] [Abstract][Full Text] [Related]
8. Principles for designing an optimal mRNA lipid nanoparticle vaccine.
Kon E; Elia U; Peer D
Curr Opin Biotechnol; 2022 Feb; 73():329-336. PubMed ID: 34715546
[TBL] [Abstract][Full Text] [Related]
9. Development of a high-throughput platform for screening lipid nanoparticles for mRNA delivery.
Cui L; Pereira S; Sonzini S; van Pelt S; Romanelli SM; Liang L; Ulkoski D; Krishnamurthy VR; Brannigan E; Brankin C; Desai AS
Nanoscale; 2022 Jan; 14(4):1480-1491. PubMed ID: 35024714
[TBL] [Abstract][Full Text] [Related]
10. Research Advances on the Stability of mRNA Vaccines.
Cheng F; Wang Y; Bai Y; Liang Z; Mao Q; Liu D; Wu X; Xu M
Viruses; 2023 Mar; 15(3):. PubMed ID: 36992377
[TBL] [Abstract][Full Text] [Related]
11. mRNA Vaccines: The Dawn of a New Era of Cancer Immunotherapy.
Deng Z; Tian Y; Song J; An G; Yang P
Front Immunol; 2022; 13():887125. PubMed ID: 35720301
[TBL] [Abstract][Full Text] [Related]
12. Current status and patent prospective of lipid nanoparticle for mRNA delivery.
Zhang HL
Expert Opin Ther Pat; 2023 Feb; 33(2):125-131. PubMed ID: 36958374
[TBL] [Abstract][Full Text] [Related]
13. The clinical progress and challenges of mRNA vaccines.
Yu MZ; Wang NN; Zhu JQ; Lin YX
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2023; 15(5):e1894. PubMed ID: 37096256
[TBL] [Abstract][Full Text] [Related]
14. Development and applications of mRNA treatment based on lipid nanoparticles.
Wang Z; Ma W; Fu X; Qi Y; Zhao Y; Zhang S
Biotechnol Adv; 2023; 65():108130. PubMed ID: 36933868
[TBL] [Abstract][Full Text] [Related]
15. An imidazole modified lipid confers enhanced mRNA-LNP stability and strong immunization properties in mice and non-human primates.
Ripoll M; Bernard MC; Vaure C; Bazin E; Commandeur S; Perkov V; Lemdani K; Nicolaï MC; Bonifassi P; Kichler A; Frisch B; Haensler J
Biomaterials; 2022 Jul; 286():121570. PubMed ID: 35576809
[TBL] [Abstract][Full Text] [Related]
16. Chemistry of Lipid Nanoparticles for RNA Delivery.
Eygeris Y; Gupta M; Kim J; Sahay G
Acc Chem Res; 2022 Jan; 55(1):2-12. PubMed ID: 34850635
[TBL] [Abstract][Full Text] [Related]
17. Recent progress in mRNA cancer vaccines.
Yao R; Xie C; Xia X
Hum Vaccin Immunother; 2024 Dec; 20(1):2307187. PubMed ID: 38282471
[TBL] [Abstract][Full Text] [Related]
18. Current Status and Future Perspectives on MRNA Drug Manufacturing.
Webb C; Ip S; Bathula NV; Popova P; Soriano SKV; Ly HH; Eryilmaz B; Nguyen Huu VA; Broadhead R; Rabel M; Villamagna I; Abraham S; Raeesi V; Thomas A; Clarke S; Ramsay EC; Perrie Y; Blakney AK
Mol Pharm; 2022 Apr; 19(4):1047-1058. PubMed ID: 35238565
[TBL] [Abstract][Full Text] [Related]
19. A Biopharmaceutical Perspective on Higher-Order Structure and Thermal Stability of mRNA Vaccines.
Kloczewiak M; Banks JM; Jin L; Brader ML
Mol Pharm; 2022 Jul; 19(7):2022-2031. PubMed ID: 35715255
[TBL] [Abstract][Full Text] [Related]
20. Comparative immunogenicity of an mRNA/LNP and a DNA vaccine targeting HIV
Valentin A; Bergamaschi C; Rosati M; Angel M; Burns R; Agarwal M; Gergen J; Petsch B; Oostvogels L; Loeliger E; Chew KW; Deeks SG; Mullins JI; Pavlakis GN; Felber BK
Front Immunol; 2022; 13():945706. PubMed ID: 35935984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
